On March 17, 2021, Xi’an Health Commission reported a domestic COVID-19 case. The patient was a 36-year-old female laboratorian working in a hospital designated for treatment of imported COVID-19 cases. That day she was febrile, with a temperature of 37.9 °C; she had a cough and headache. She reported no dyspnea or shortness of breath. Chest computed tomography (CT) revealed flocculent shadows in both lungs. Throat swabs and blood samples were immediately obtained. Throat swabs were positive by COVID-19-specific quantitative reverse-transcription polymerase chain reaction (qRT-PCR), with the cycle threshold (Ct) values of 34 for N gene and 35.27 for ORF1ab fragment (Figure 1). Rapid COVID-19 antibody tests were weakly positive for IgG and negative for IgM. She was diagnosed as a confirmed COVID-19 case (regular type).
An epidemiological investigation was immediately launched. She had been healthy without fever or other relevant abnormalities during the 14 days before starting work in the isolation area on March 4. She had been vaccinated with inactivated COVID-19 vaccine (Beijing Institute of Biological Products Co. LTD) on December 30, 2020 and again on January 20, 2021. She and her 33 workmates were working in the isolation area for a 3-week period. She lived in the dormitory in an area separate from the isolation wards. She lived and shared a bathroom in the dormitory with one colleague. On March 2 and March 11, she tested negative for COVID-19 by qRT-PCR in the hospital’s routine testing of staff. Her main work was obtaining throat swabs for COVID-19 cases in the isolation wards and conducting blood, urine, and feces testing in the isolation area’s BSL-2 laboratory. She alternated every other day with another laboratorian for this work. Medical history review showed that she has chronic rhinitis and usually breathes by mouth when wearing a mask.
After diagnosis, she was immediately transferred to the isolation ward for medical treatment and observation. Her highest temperature was 37.2 °C, recorded on March 19. Her cough increased slightly. She described dry mouth and mildly decreased sense of smell. Rapid testing for COVID-19 virus antibody showed IgG positive and IgM weakly positive. Chemiluminescence assay for total COVID-19 virus antibody appeared strongly positive with a cutoff index (COI) of 1,368 (Figure 1). On March 20, her temperature was normal, and her sense of smell improved slightly. Viral qRT-PCR was positive for N gene (Ct: 37) and negative for ORF1ab. Her temperature remained normal and all other symptoms disappeared in the following days. Her oxygen saturation was never below 98% and she never required supplemental oxygen. The patient remained in the isolation hospital due to weakly positive qRT-PCR. On April 9, she recovered and was discharged from the isolation ward.
Whole viral genome sequencing was conducted on an insolate from a throat swab specimen obtained on March 17. Due to the low viral load of the sample, sequences covering only 82% of the entire genome were obtainable. Sequence analysis revealed that the virus was a COVID-19 variant B.1.1.7 lineage virus and that it had high homology with isolates from 2 COVID-19 patients in the isolation ward who had returned to China from Uzbekistan on March 5.
The patient had two close contacts with both of the returnees from Uzbekistan. With assistance from other nurses, she obtained nasopharyngeal swabs (left and right nares) and an oropharyngeal swab from each returnee on March 6 and again on March 12. As shown in Figure 1, the 2 returnees had strongly positive qRT-PCR test results, with Ct values of the 3 targeted genes ranging from 11.84 to 14.85 in the March 6 samples and from 21.21 to 28.57 in the March 12 samples. During interviews with her and her colleagues, she indicated that she was well trained in use of personal protective equipment (PPE) and conducted medical procedures precisely, according to standard operating procedures.
The 33 colleagues on her team were transferred to another designated hospital for quarantine. Three serial qRT-PCR tests, conducted between March 17 and March 19, were all negative. None of the team members became febrile or ill. Prior to working in the isolation are, all 33 staff had been vaccinated with the same type of inactivated COVID-19 vaccine; 30 staff completed 2-dose regimens, while 3 received only 1 dose due to personal reasons. Blood samples from all 33 staff were obtained on March 19 and the levels of COVID-19 virus total antibody, IgG, and IgM were measured by chemiluminescence. As shown in Figure 2, all 30 fully vaccinated staff were positive in total antibody with an average COI of 19.77 (ranging from 1.7 to 150.83) and positive in IgG with an average COI of 20.29 (ranging from 3.69 to 64.33). The 3 staff who received 1 dose of vaccine tested negative (COI<1.0) in total antibody; 2 of the 3 were also IgG negative; 15 of the 30 fully vaccinated individuals were positive in IgM, while the 3 recipients that received 1-dose were negative. On Day 6, 13, 20, and 27 after quarantine, the 33 staff were tested again with qRT-PCR and all tested negative.
More than 3,000 healthcare workers and their family members were asked to stay at their work place or at home. All tested negative by qRT-PCR. Hundreds of environmental samples were obtained, including in the dormitory, isolation area, and other buildings of the hospital. Other than positive samples from the patient’s room, all environmental samples were negative by qRT-PCR.